✦ LIBER ✦

Dynamic-Contrast Enhanced MR and Volume Regression Rate as a Preoperative Predictive Assay in Patients With Non-Small Cell Lung Cancer

✍ Scribed by Grecula, J.C.; Elias, S.; Thelen, K.; Knopp, M.; Otterson, G.; Ross, P.; Kassis, E.; Welliver, M.; Villalona-Calero, M.; Shilo, K.; Lo, S.; Jia, G.; Yu, W.C.; Yuh, B.; Ghosh, S.; Bertino, E.; Mayr, N.

Book ID: 127110367
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 54 KB
Volume: 90
Category: Article
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2014.05.2353

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

JOURNAL CLUB: Comparison of Assessment o

JOURNAL CLUB: Comparison of Assessment of Preoperative Pulmonary Vasculature in Patients With Non–Small Cell Lung Cancer by Non–Contrast- and 4D Contrast-Enhanced 3-T MR Angiography and Contrast-Enhanced 64-MDCT

✍ Ohno, Yoshiharu; Nishio, Mizuho; Koyama, Hisanobu; Yoshikawa, Takeshi; Matsumoto 📂 Article 📅 2014 🏛 American Roentgen Ray Society 🌐 English ⚖ 967 KB

Dynamic contrast-enhanced CT in patients

Dynamic contrast-enhanced CT in patients treated with sorafenib and erlotinib for non-small cell lung cancer: a new method of monitoring treatment?

✍ Joline S. W. Lind; Martijn R. Meijerink; Anne-Marie C. Dingemans; Cornelis van K 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 308 KB

ERCC1 expression as a prognostic and pre

ERCC1 expression as a prognostic and predictive factor in patients with non-small cell lung cancer: a meta-analysis

✍ Jingwei Jiang; Xiaohua Liang; Xinli Zhou; Ruofan Huang; Zhaohui Chu; Qiong Zhan 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 548 KB

Dynamic contrast-enhanced CT to assess m

Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy

✍ Sung Ho Hwang, Mi Ri Yoo, Chul Hwan Park, Tae Joo Jeon, Sang Jin Kim… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 438 KB

6554 POSTER Serum sialyl Lewisx and cyto

6554 POSTER Serum sialyl Lewisx and cytokeratin 19 fragment as a predictive factors for recurrence in patients with stage I non-small cell lung cancer

✍ Mizuguchi, S.; Nishiyama, N.; Iwata, T.; Nishida, T.; Izumi, N.; Tsukioka, T.; I 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 57 KB

P-546 Thiol-disulfide ratio (TDR) in blo

P-546 Thiol-disulfide ratio (TDR) in blood as a predictive in vitro test for treatment effect evaluation and individual chemotherapy (CT) choice in patients with advanced non-small cell lung cancer (NSCLC)

✍ Obodnikov, Oleksandr O.; Parshikov, Oleksandr; Orlovskiy, Oleksiy 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 187 KB